Literature DB >> 12790157

Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models.

Susan Rotzinger1, Franco J Vaccarino.   

Abstract

Cholecystokinin (CCK) is an abundant and widely distributed neuropeptide that plays a modulatory role in a variety of behaviours. This paper focuses on the role of CCK in modulating anxiety-related and reward-related behaviours in key brain regions of the amygdala and mesolimbic dopamine system, respectively. The role of CCK in mediating aspects of these behaviours has been studied in a variety of behavioural paradigms, but inconsistent results have led to confusion regarding the precise role of the receptor subtypes in mediating behaviour. The confusion in the literature may come in part from the diverse behavioural paradigms that are used, the differences in regional effects of CCK manipulations in different areas and at different receptor subtypes in these areas and the dependence of the behavioural outcome on the baseline state of arousal of the animal. Evidence on the role of CCK in anxiety-related and reward-related behaviours in various animal models indicates that CCK-B receptors in the basolateral amygdala are important mediators of anxiety-related behaviours and that CCK-A and CCK-B receptors in the nucleus accumbens are important in mediating different aspects of reward-related behaviour. Emphasis is placed upon the role of CCK as a neuromodulator that is recruited only under conditions of high frequency neuronal firing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12790157      PMCID: PMC161741     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  128 in total

Review 1.  Drugs of abuse and the brain.

Authors:  A I Leshner; G F Koob
Journal:  Proc Assoc Am Physicians       Date:  1999 Mar-Apr

2.  The dopamine D-1 receptor antagonist SCH 23390 injected into the dorsolateral bed nucleus of the stria terminalis decreased cocaine reinforcement in the rat.

Authors:  M P Epping-Jordan; A Markou; G F Koob
Journal:  Brain Res       Date:  1998-02-16       Impact factor: 3.252

3.  Forebrain projections from cholecystokininlike-immunoreactive neurons in the rat midbrain.

Authors:  K B Seroogy; J H Fallon
Journal:  J Comp Neurol       Date:  1989-01-15       Impact factor: 3.215

Review 4.  The cholecystokinin hypothesis of anxiety and panic disorder.

Authors:  J Bradwejn; D Koszycki
Journal:  Ann N Y Acad Sci       Date:  1994-03-23       Impact factor: 5.691

5.  Corticotropin releasing factor produces behavioural activation in rats.

Authors:  R E Sutton; G F Koob; M Le Moal; J Rivier; W Vale
Journal:  Nature       Date:  1982-05-27       Impact factor: 49.962

6.  A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing.

Authors:  T Hökfelt; L Skirboll; J F Rehfeld; M Goldstein; K Markey; O Dann
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

Review 7.  Involvement of cholecystokinin within craving for cocaine: role of cholecystokinin receptor ligands.

Authors:  F Crespi; M Corsi; A Reggiani; E Ratti; G Gaviraghi
Journal:  Expert Opin Investig Drugs       Date:  2000-10       Impact factor: 6.206

8.  Increased dopamine metabolism in the nucleus accumbens and striatum following consumption of a nutritive meal but not a palatable non-nutritive saccharin solution.

Authors:  J R Blackburn; A G Phillips; A Jakubovic; H C Fibiger
Journal:  Pharmacol Biochem Behav       Date:  1986-11       Impact factor: 3.533

9.  Effects of cholecystokinin octapeptide on thermoregulatory responses and hypothalamic neuronal activity in the rat.

Authors:  L R Shian; M T Lin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

Review 10.  Two faces of cholecystokinin: anxiety and schizophrenia.

Authors:  M Bourin; M Malinge; E Vasar; J Bradwejn
Journal:  Fundam Clin Pharmacol       Date:  1996       Impact factor: 2.748

View more
  34 in total

1.  Neurotransmitter interactions in psychotropic drug action: beyond dopamine and serotonin.

Authors:  Andrew J Greenshaw
Journal:  J Psychiatry Neurosci       Date:  2003-07       Impact factor: 6.186

2.  Wiring and volume transmission in rat amygdala. Implications for fear and anxiety.

Authors:  Miguel Pérez de la Mora; Kirsten X Jacobsen; Minerva Crespo-Ramírez; Candy Flores-Gracia; Kjell Fuxe
Journal:  Neurochem Res       Date:  2008-05-13       Impact factor: 3.996

Review 3.  Molecular mechanisms of dopaminergic subset specification: fundamental aspects and clinical perspectives.

Authors:  Jesse V Veenvliet; Marten P Smidt
Journal:  Cell Mol Life Sci       Date:  2014-07-27       Impact factor: 9.261

Review 4.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

5.  Interoceptive "satiety" signals produced by leptin and CCK.

Authors:  Scott E Kanoski; Elwood K Walls; T L Davidson
Journal:  Peptides       Date:  2007-03-03       Impact factor: 3.750

6.  Brain expression and song regulation of the cholecystokinin gene in the zebra finch (Taeniopygia guttata).

Authors:  Peter V Lovell; Claudio V Mello
Journal:  J Comp Neurol       Date:  2011-02-01       Impact factor: 3.215

7.  Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats.

Authors:  Allison T Knoll; John W Muschamp; Stephanie E Sillivan; Deveroux Ferguson; David M Dietz; Edward G Meloni; F Ivy Carroll; Eric J Nestler; Christine Konradi; William A Carlezon
Journal:  Biol Psychiatry       Date:  2011-04-30       Impact factor: 13.382

8.  Genetic analysis of a population heavy drinking phenotype identifies risk variants in whites.

Authors:  Ajna Hamidovic; Robert J Goodloe; Taylor R Young; Mindi A Styn; Kenneth J Mukamal; Helene Choquet; Jay L Kasberger; Sarah G Buxbaum; George J Papanicolaou; Wendy White; Kelly Volcik; Bonnie Spring; Brian Hitsman; Daniel Levy; Eric Jorgenson
Journal:  J Clin Psychopharmacol       Date:  2013-04       Impact factor: 3.153

Review 9.  How might circadian rhythms control mood? Let me count the ways...

Authors:  Colleen A McClung
Journal:  Biol Psychiatry       Date:  2013-04-01       Impact factor: 13.382

10.  Effect of intranasally administered cholecystokinin on encoding of controlled and automatic memory processes.

Authors:  Ronald Schneider; Judith Osterburg; Axel Buchner; Reinhard Pietrowsky
Journal:  Psychopharmacology (Berl)       Date:  2008-10-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.